{"title": "Vacunas chinas contra COVID-19 muestran datos de seguridad y eficacia, seg\u00fan OMS", "author": null, "url": null, "hostname": null, "description": "GINEBRA, 2 abr (Xinhua) -- Las farmac\u00e9uticas chinas Sinopharm y Sinovac han presentado datos sobre sus vacunas contra la COVID-19 que demuestran su seguridad y buena eficacia contra la enfermedad.", "sitename": null, "date": "2021-04-03", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "GINEBRA, 2 abr (Xinhua) -- Las farmac\u00e9uticas chinas Sinopharm y Sinovac han presentado datos sobre sus vacunas contra la COVID-19 que demuestran su seguridad y buena eficacia contra la enfermedad.\nAs\u00ed lo afirm\u00f3 el mi\u00e9rcoles en rueda de prensa el presidente del Grupo Asesor Estrat\u00e9gico de Expertos en Inmunizaci\u00f3n (SAGE) de la Organizaci\u00f3n Mundial de la Salud (OMS), Alejandro Cravioto.\nSeg\u00fan explic\u00f3, la informaci\u00f3n que las dos empresas compartieron de forma p\u00fablica en la reuni\u00f3n del SAGE la semana pasada indica claramente que \"tienen niveles de eficacia que ser\u00edan compatibles con los requisitos que la OMS ha solicitado para esta vacuna\".\n\"Tienen todos los datos de seguridad para demostrar que esta vacuna no causar\u00eda da\u00f1o en humanos\", agreg\u00f3.(Web editor: \u5434\u601d\u8431, \u8d75\u5065)", "language": null, "image": null, "pagetype": null, "links": ["http://spanish.peopledaily.com.cn/", "http://spanish.peopledaily.com.cn/", "http://spanish.peopledaily.com.cn/31621/index.html", "http://spanish.peopledaily.com.cn/31620/index.html", "http://spanish.peopledaily.com.cn/31618/index.html", "http://spanish.peopledaily.com.cn/31617/index.html", "http://spanish.peopledaily.com.cn/31619/index.html", "http://spanish.peopledaily.com.cn//92121/index.html", "http://spanish.peopledaily.com.cn/31615/index.html", "http://spanish.peopledaily.com.cn//92122/index.html", "http://spanish.peopledaily.com.cn/31614/index.html", "http://spanish.peopledaily.com.cn/204699/index.html", "http://spanish.peopledaily.com.cn/31613/index.html", "http://spanish.peopledaily.com.cn//101336/index.html", "http://spanish.peopledaily.com.cn/205763/index.html", "http://spanish.peopledaily.com.cn/", "http://spanish.peopledaily.com.cn/31618/", "http://spanish.xinhuanet.com/", "http://103.42.76.205/spain/index.php/comment/netuser/9835693", "/n3/2017/0620/c31614-9230854.html", "/n3/2017/0620/c92122-9230905.html", "/n3/2017/0621/c92121-9231296.html", "/n3/2017/0621/c31614-9231439.html", "/n3/2017/0621/c31620-9231352.html", "/n3/2017/0621/c31620-9231441.html", "/n3/2017/0621/c31619-9231418.html", "/n3/2021/0402/c31614-9835520.html", "/n3/2021/0402/c31614-9835520.html", "/n3/2021/0402/c31614-9835486.html", "/n3/2021/0402/c31614-9835486.html", "/n3/2021/0402/c31614-9835365.html", "/n3/2021/0402/c31614-9835365.html", "/n3/2021/0401/c92122-9834981.html", "/n3/2021/0401/c92122-9834981.html", "/n3/2021/0401/c31621-9834903.html", "/n3/2021/0401/c31621-9834903.html", "/n3/2021/0331/c31614-9834506.html", "/n3/2021/0331/c31614-9834506.html", "/n3/2021/0331/c92121-9834495.html", "/n3/2021/0331/c92121-9834495.html", "/n3/2021/0331/c92122-9834465.html", "/n3/2021/0331/c92122-9834465.html", "/n3/2021/0331/c92121-9834443.html", "/n3/2021/0331/c31620-9834436.html", "/n3/2021/0331/c31620-9834436.html"]}